Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors

Journal of Computer Assisted Tomography

Volumn 37, Issue 1, 2013, Pages 9-14

  Sharma, Amita ^a   Lanuti, Michael ^a   He, Wei ^a   Palmer, Edwin L ^a   Shepard, Jo Anne O ^a   Digumarthy, Subba R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ablation; CT; FDG PET; follow up; interventional radiology; lung cancer; lung tumors; percutaneous CT guided; radiofrequency; radiology; technique; treatment

Indexed keywords

ABLATION; BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; ELECTRODES; HISTOLOGY; PATIENT TREATMENT; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RADIATION; RADIOLOGY;

CT; FDG PET; FOLLOW UP; INTERVENTIONAL RADIOLOGY; LUNG CANCER; LUNG TUMOR; PERCUTANEOUS CT-GUIDED; RADIOFREQUENCIES; TECHNIQUE; TREATMENT;

TUMORS;

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CLINICAL ARTICLE; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LUNG EMPHYSEMA; LUNG TUMOR; MALE; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR VOLUME;

EID: 84872923661     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182732341     Document Type: Article

References (25)

1. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268-275. (Pubitemid 46579719)
2. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: A potential complementary therapy for patients with unresectable primary lung cancerYa preliminary report of 33 patients. AJR Am J Roentgenol. 2004;183:1003-1011. (Pubitemid 44185086)
3. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg. 2006;30:177-183. (Pubitemid 43850341)
4. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005;129:639-644. (Pubitemid 40311325)
5. Gadaleta C, Catino A, Ranieri G, et al. Radiofrequency thermal ablation of 69 lung neoplasms. J Chemother. 2004;16(suppl 5):86-89. (Pubitemid 40053000)
6. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg. 2007;134:1306-1312. (Pubitemid 47633617)
7. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol. 2007;18:1264-1269. (Pubitemid 47446262)
8. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:160-166.
9. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: A multicenter study in Japan. J Vasc Interv Radiol. 2007;18:393-398. (Pubitemid 46616705)
10. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: Initial experience. Radiology. 2004;231:850-857. (Pubitemid 38668108)
11. Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: Correlation between CT and histopathologic findings. AJR Am J Roentgenol. 2005;185:1299-1306.
12. Tominaga J, Miyachi H, Ishibashi T, et al. Correlation between CT and pathological findings after radiofrequency ablation of rabbit lung: Evaluation of therapeutic effective area. Nippon Igaku Hoshasen Gakkai Zasshi. 2004;64:305-306.
13. Glazer GM, Gross BH, Quint LE, et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol. 1985;144:261-265. (Pubitemid 15168325)
14. Okuma T, Matsuoka T, Okamura T, et al. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med. 2006;47:1351-1358. (Pubitemid 47544891)
15. Okuma T, Okamura T, Matsuoka T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med. 2006;20:115-121.
16. Okuma T, Matsuoka T, Yamamoto A, et al. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: A pilot study. Br J Radiol. 2009;82:989-994.
17. Tominaga J, Miyachi H, Takase K, et al. Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study. J Vasc Interv Radiol. 2005;16:1719-1726. (Pubitemid 44431171)
18. Kang S, Luo R, Liao W, et al. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol. 2004;2:30.
19. Higaki F, Okumura Y, Sato S, et al. Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Ann Nucl Med. 2008;22:157-163. (Pubitemid 351729622)
20. Sharma A, Digumarthy SR, Kalra MK, et al. Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors. AJR Am J Roentgenol. 2010;194:1250-1256.
21. Yoo DC, Dupuy DE, Hillman SL, et al. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: Are early posttreatment PET findings predictive of treatment outcome? AJR Am J Roentgenol. 2011;197:334-340.
22. Singnurkar A, Solomon SB, Gonen M, et al. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. J Nucl Med. 2010;51:1833-1840.
23. Deandreis D, Leboulleux S, Dromain C, et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology. 2011;258:270-276.
24. Khandani AH, Calvo BF, O'Neil BH, et al. A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases. AJR Am J Roentgenol. 2007;189:1199-1202. (Pubitemid 350033017)
25. Kuehl H, Antoch G, Stergar H, et al. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: Initial results. Eur J Radiol. 2008;67:362-371.